ProfileGDS4177 / 228747_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 37% 31% 61% 67% 49% 46% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated20.1837
GSM603099KU-812 non-treated15.2831
GSM603098KCL-22 Imatinib-treated56.8761
GSM603097KCL-22 non-treated79.5867
GSM603102JURL-MK1 Imatinib-treated32.0849
GSM603101JURL-MK1 non-treated27.6746